Canoe Financial LP Sells 67,471 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Canoe Financial LP lessened its position in HCA Healthcare, Inc. (NYSE:HCA) by 29.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 164,123 shares of the company’s stock after selling 67,471 shares during the quarter. Canoe Financial LP owned about 0.07% of HCA Healthcare worth $56,713,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. Sanders Capital LLC raised its holdings in HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after acquiring an additional 116,826 shares during the period. First Eagle Investment Management LLC increased its holdings in shares of HCA Healthcare by 0.5% during the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after purchasing an additional 23,177 shares during the period. Geode Capital Management LLC increased its holdings in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after purchasing an additional 50,321 shares during the period. Capital World Investors increased its holdings in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after purchasing an additional 19,121 shares during the period. Finally, Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter worth about $840,286,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on HCA shares. Guggenheim began coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a “neutral” rating on the stock. Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the company an “equal weight” rating in a research report on Monday, June 9th. Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating on the stock in a research report on Monday, April 28th. Finally, Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $392.47.

HCA Healthcare Stock Up 0.1%

Shares of NYSE:HCA opened at $377.26 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The company has a market capitalization of $90.76 billion, a PE ratio of 16.77, a PEG ratio of 1.30 and a beta of 1.49. The company has a 50 day moving average price of $362.30 and a two-hundred day moving average price of $334.77.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the firm earned $5.36 earnings per share. The business’s quarterly revenue was up 5.7% on a year-over-year basis. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.81%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.